Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

videos

Helena Yu, MD
Videos
EGFR: First Line, Second Line and Beyond in the Age of Osimertinib
11/07/2022
Helena Yu, MD, shares exciting new developments and potential treatments in the first- and second-line settings for patients with EGFR-mutated lung cancer, a topic she presented at the 2022 Great Debates and Updates in Lung Cancer.
Helena Yu, MD, shares exciting new developments and potential treatments in the first- and second-line settings for patients with EGFR-mutated lung cancer, a topic she presented at the 2022 Great Debates and Updates in Lung Cancer.
Helena Yu, MD, shares exciting...
11/07/2022
Oncology
Raj Veluswamy, MD, Icahn School of Medicine, New York
Videos
NTRK: Front-Line and Second-Line Treatment Options for Patients With NSCLC
10/15/2022
Rajwanth Veluswamy, MD, provides an overview of his presentation at Great Debates and Updates in Lung Cancer covering front-line and second-line treatment options for patients with NSCLC and NTRK fusions.
Rajwanth Veluswamy, MD, provides an overview of his presentation at Great Debates and Updates in Lung Cancer covering front-line and second-line treatment options for patients with NSCLC and NTRK fusions.
Rajwanth Veluswamy, MD, provides...
10/15/2022
Oncology
Kristin Higgins, MD, Winship Cancer Institute, GA
Videos
SRS and Other Local Ablative Strategies in Patients With NSCLC and Oligometastases
10/15/2022
Dr Kristin Higgins provides an overview of her presentation at Great Debates and Updates in Lung Cancer covering ablative radiation & other local modalities in systemically treated patients with NSCLC and oligometastases.
Dr Kristin Higgins provides an overview of her presentation at Great Debates and Updates in Lung Cancer covering ablative radiation & other local modalities in systemically treated patients with NSCLC and oligometastases.
Dr Kristin Higgins provides an...
10/15/2022
Oncology
Nasser Altorki, MD, Weill Cornell Medical College
Videos
Adjuvant Checkpoint Inhibitors in Resectable NSCLC
10/15/2022
Dr Nasser Altorki reviews his presentation on adjuvant checkpoint inhibitors for patients with resectable non-small cell lung cancer, from the 2022 Great Debates and Updates in Lung Cancer meeting in New York.
Dr Nasser Altorki reviews his presentation on adjuvant checkpoint inhibitors for patients with resectable non-small cell lung cancer, from the 2022 Great Debates and Updates in Lung Cancer meeting in New York.
Dr Nasser Altorki reviews his...
10/15/2022
Oncology
Corey Langer, MD, Director of Thoracic Oncology, Abramson Cancer Center, Hospital of the University of Pennsylvania
Videos
Immune Checkpoint Inhibitors Improve Treatment Outcomes in Malignant Pleural Mesothelioma
09/22/2022
Corey Langer, MD, provides an overview on the potential of immune checkpoint inhibitors for the treatment of malignant pleural mesothelioma, a topic he presented at the 2022 GDU Lung Cancers virtual meeting.
Corey Langer, MD, provides an overview on the potential of immune checkpoint inhibitors for the treatment of malignant pleural mesothelioma, a topic he presented at the 2022 GDU Lung Cancers virtual meeting.
Corey Langer, MD, provides an...
09/22/2022
Oncology
Corey Langer, MD, Director of Thoracic Oncology at the Abramson Cancer Center at the University of Pennsylvania
Videos
Potential Impact of Immune Checkpoint Inhibitors in Thymic Malignancies
09/22/2022
Corey Langer, MD, provides an overview on the potential for immune checkpoint inhibitors in the treatment of thymic malignancies, a topic he presented at the 2022 GDU Lung Cancers virtual meeting.
Corey Langer, MD, provides an overview on the potential for immune checkpoint inhibitors in the treatment of thymic malignancies, a topic he presented at the 2022 GDU Lung Cancers virtual meeting.
Corey Langer, MD, provides an...
09/22/2022
Oncology
Edward Garon, MD, MS, David Geffen School of Medicine, University of California Los Angeles
Videos
Dr Edward Garon on the Basics of Immunotherapy in Lung Cancer
09/14/2022
Edward Garon, MD, MS, provides an overview on the basics of immunotherapy for NSCLC and SCLC, a topic he presented at the virtual 2022 GDU Lung Cancers meeting.
Edward Garon, MD, MS, provides an overview on the basics of immunotherapy for NSCLC and SCLC, a topic he presented at the virtual 2022 GDU Lung Cancers meeting.
Edward Garon, MD, MS, provides...
09/14/2022
Oncology
Lyudmila Bazhenova, MD, Talks About Immune-Related AEs in Lung Cancer
Videos
Lyudmila Bazhenova, MD, Talks About Immune-Related AEs in Lung Cancer
03/25/2020
Dr Bazhenova talks about the management of immune-related adverse events in patients with lung cancer.
Dr Bazhenova talks about the management of immune-related adverse events in patients with lung cancer.
Dr Bazhenova talks about the...
03/25/2020
Oncology
Remarkable Breakthroughs in the Treatment of Advanced NSCLC
Videos
Remarkable Breakthroughs in the Treatment of Advanced NSCLC
03/22/2020
Martin J. Edelman, MD, discusses how the treatment landscape for advanced NSCLC has evolved in recent years.
Martin J. Edelman, MD, discusses how the treatment landscape for advanced NSCLC has evolved in recent years.
Martin J. Edelman, MD, discusses...
03/22/2020
Oncology
The Future of Lung Cancer Screening
Videos
The Future of Lung Cancer Screening
03/03/2020
James L. Mulshine, MD, talks about what the future holds vis-a-vis advancements in lung cancer screening.
James L. Mulshine, MD, talks about what the future holds vis-a-vis advancements in lung cancer screening.
James L. Mulshine, MD, talks...
03/03/2020
Oncology

Advertisement

About

Formerly known as Perspectives in Thoracic Oncology, the lung cancer meeting you know and love is getting a makeover. With an updated name to reflect a more pronounced focus on targeted therapies, biomarker testing and precision medicine, year 25 of this educational gathering is getting practical. Personalized Therapies in Thoracic Oncology will go beyond chemotherapy and focus on the best way to treat your patients when traditional methods aren't cutting it. 

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use